RIC-8A Antibodies

Santa Cruz Biotechnology features a diverse variety of RIC-8A monoclonal antibodies for research in understanding RIC-8A's role in cellular processes. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RIC-8A, also known as Resistance to Inhibitors of Cholinesterase 8A, is a guanine nucleotide exchange factor that plays a critical role in the activation of G-proteins. RIC-8A is essential for proper neuronal signaling and influences various physiological processes, including synaptic transmission and cellular signaling pathways. Research has shown RIC-8A's significance in neurodevelopmental disorders and other diseases. Scientists can investigate RIC-8A's expression patterns across different tissues and cell types. Researchers can examine RIC-8A's interactions with other proteins and its role in signal transduction pathways. Understanding RIC-8A's molecular mechanisms can provide valuable insights into potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of RIC-8A's role in health and disease.